Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02097329 · ClinicalTrials.gov registry record · Phase 1

Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food

A Phase 1 study of Healthy, sponsored by Pfizer.

Completed
Registry status
Phase 1
Development phase
27
Enrollment target
1
Study location

NCT02097329 is a Phase 1 study of Healthy that has completed, run by Pfizer. The registered enrollment target is 27 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02097329, a Phase 1 study of Healthy, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

To investigate the effect of acid reducing agents (an antacid and an H2-receptor antagonist and a proton pump inhibitor) on palbociclib bioavailability in the presence of food.

Conditions Studied

Healthy

Interventions

  • DRUG rabeprazole
  • DRUG palbociclib commercial free base
  • DRUG famotidine
  • DRUG antacid

Study Locations (1)

Connecticut

  • Pfizer Investigational Site - New Haven

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2014-04
Est. Completion 2014-06
Phase Phase 1

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02097329

The ClinicalTrials.gov registry entry for NCT02097329 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which rabeprazole is the first listed.

NCT02097329 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02097329 about?

NCT02097329 is a clinical study titled "Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food". To investigate the effect of acid reducing agents (an antacid and an H2-receptor antagonist and a proton pump inhibitor) on palbociclib bioavailability in the presence of food.

What is the current status of trial NCT02097329?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2014-04. Estimated completion is 2014-06.

What conditions does trial NCT02097329 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02097329?

The interventions under investigation include: rabeprazole (DRUG), palbociclib commercial free base (DRUG), famotidine (DRUG), antacid (DRUG).

Who is sponsoring clinical trial NCT02097329?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02097329 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.